Sponsors (2)
The bill improves consumer protection and product integrity for olive oil by creating clear grades and testing standards, but it raises compliance and administrative costs that could burden smaller producers and require federal resources.
Consumers will get clearer, enforceable olive oil grade definitions and labeling, making it easier to identify products that match advertised quality.
Consumers benefit from standardized accredited analytical methods and PPP/DAG parameters (AOCS/ISO/IOOC), which reduce adulteration and improve product quality verification and safety.
U.S. producers and bottlers gain a clearer regulatory framework to market and differentiate genuine grades, which can increase consumer trust and support premium pricing for authentic products.
Producers and importers will face new compliance costs to perform testing to PPP/DAG standards and use accredited analytical methods, raising production and labeling expenses.
Smaller domestic and foreign producers lacking access to accredited testing could be disadvantaged or temporarily excluded from some markets until they meet the standards.
Federal agencies (e.g., FDA/HHS) will incur administrative and enforcement costs to develop and implement the new standards, potentially requiring funding or diverting staff time.
Based on analysis of 2 sections of legislative text.
Introduced December 16, 2025 by Josh Harder · Last progress December 16, 2025
Directs the Secretary of Health and Human Services (through the FDA Commissioner) to establish a federal standard of identity and U.S. grade standards for eight named olive oil and olive‑pomace oil grades. The rule must set quality and purity parameters, require accredited laboratory methods for analysis, impose mandatory labeling that matches the stated grade and avoids misleading package copy, and include specific chemical markers (pyropheophytin a and 1,2‑diacylglycerols) for extra virgin olive oil; the Secretary must report to Congress on actions taken within 120 days of enactment.